What is Levocin (Amoxicillin)?
Levocin is a brand name for amoxicillin, a semisynthetic penicillin-class antibacterial agent with broad-spectrum bactericidal activity against many Gram-positive and Gram-negative microorganisms. 1
Chemical Composition and Formulation
Amoxicillin is chemically described as (2S,5R,6R)-6-[(R)-(-)-2-amino-2-(p-hydroxyphenyl)acetamido]-3-3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid trihydrate, with molecular formula C₁₆H₁₉N₃O₅S·3H₂O and molecular weight of 419.45 1
Available as oral suspension in 125 mg/5 mL and 250 mg/5 mL concentrations 1
Mechanism of Action and Spectrum
Amoxicillin is generally considered the most active of all oral β-lactams against streptococci, including pneumococci, due to its intrinsic activity and excellent bioavailability 2
It demonstrates bactericidal activity by inhibiting bacterial cell wall synthesis 1
The drug has fair to good intrinsic activity against β-lactamase-negative strains of Haemophilus influenzae, though it is 20 to 50 times less potent than third-generation cephalosporins against this organism 2
Clinical Indications
Amoxicillin is FDA-approved for treatment of infections in both adults and pediatric patients, including: 1
- Upper respiratory tract infections of the ear, nose, and throat 1
- Genitourinary tract infections 1
- Skin and skin structure infections 1
- Lower respiratory tract infections 1
- Helicobacter pylori infection and duodenal ulcer disease (adults only) 1
Dosing Regimens
Adults
- Standard dosing: 750 to 1,750 mg/day in divided doses every 8 to 12 hours 1
- High-dose amoxicillin is defined as 4 g/day for adults, which may be necessary to eradicate S. pneumoniae with high minimum inhibitory concentrations (MICs) 2
Pediatric Patients
- Children over 3 months: 20 to 45 mg/kg/day in divided doses every 8 to 12 hours 1
- High-dose pediatric regimen: 90 mg/kg per day for children, particularly important for penicillin-resistant S. pneumoniae 2
- Neonates and infants ≤3 months: maximum 30 mg/kg/day divided every 12 hours 1
Special Populations
- Dosage reduction required in patients with severe renal impairment (GFR <30 mL/min) 1
Guideline-Recommended Uses
Amoxicillin (with or without clavulanate) is recommended as first-choice therapy for multiple infections according to WHO and IDSA guidelines: 2
- Mild skin and soft tissue infections: Amoxicillin-clavulanic acid is listed as first choice 2
- Animal bites: Oral amoxicillin-clavulanic acid is the preferred oral treatment 2
- Impetigo: Amoxicillin-clavulanic acid is among recommended oral options 2
- Diabetic wound infections (mild): Amoxicillin-clavulanic acid is recommended 2
- COPD exacerbations: Amoxicillin with or without clavulanic acid is recommended as first-choice 2
- Acute bacterial rhinosinusitis: High-dose amoxicillin or amoxicillin-clavulanate is recommended for initial therapy 2
Pharmacokinetic Advantages
Serum levels of amoxicillin increase linearly with dose (gastrointestinal absorption is not a limiting factor), and the difference in adverse effects between lower and higher doses is negligible 2
Oral bioavailability approaches 100% 1
Approximately 20% protein-bound in blood serum 1
Primarily eliminated unchanged in urine (approximately 80%) through glomerular filtration and tubular secretion 1
Important Clinical Considerations
Contraindications
- History of serious hypersensitivity reaction (e.g., anaphylaxis or Stevens-Johnson syndrome) to amoxicillin or other beta-lactams 1
Common Adverse Reactions
- The most common adverse reactions (>1%) are diarrhea, rash, vomiting, and nausea 1
Drug Interactions
- Coadministration with probenecid is not recommended 1
- Concomitant use with oral anticoagulants may increase prothrombin time prolongation 1
- Coadministration with allopurinol increases risk of rash 1
- May reduce efficacy of oral contraceptives 1
Resistance Considerations
- Resistance to penicillin in S. pneumoniae is relative and may be overcome by using higher doses of amoxicillin 2
- When amoxicillin is selected for patients at risk for drug-resistant S. pneumoniae (recent antimicrobial use, immunodeficiency, frequent exposure to children in day care), the high-dose regimen should be used 2